Described are a sterile, ready-to-use, pharmaceutical oil-in water emulsion compositions for parenteral administration comprising:0.015 to 1.2% wt/vol of progestogen;0.5-30% wt/vol oil, wherein the oil comprises at least 85% wt/wt triglyceride;0.0425-12.5% wt/vol phospholipid;61.4-99.4% wt/vol aqueous medium;wherein the phospholipid is present in an amount of 6.8%-43% of the oil (wt/wt), and wherein the progestogen is present in an amount greater than or equal to 2.1 wt % of the oil.